Enteral Nurtrition Written Report
Enteral Nurtrition Written Report
Enteral Nurtrition Written Report
Submitted by:
Cairo, Justin
Macasling, Danielle
Page No.
I. INTRODUCTION
II. DEFINITION
IV. ALGORITHM
V. DIFFERENT ACCESS/ROUTES
i. Polymeric
ii. Elemental/Semi-elemental
iii. Modular
b. Pediatric Formulas
i. Polymeric
ii. Elemental/Semi-Elemental
iii. Modular
a. Renal
b. Diabetes
c. Cancer
d. Lung Injury
X. REFERENCES
I. Introduction
All humans need food to live. Sometimes a person cannot eat any or enough
food because of an illness. Others may have a decreased appetite, difficulties in
swallowing, or some type of surgery that interferes with eating. When this occurs, and
one is unable to eat, nutrition must be supplied in a different way. One method is
“enteral nutrition” or “tube feeding.”
Normal digestion occurs when food is broken down in the stomach and small
intestine, then absorbed in the bowels. These absorbed products are carried by the
blood to all parts of the body (ASPEN, 2008). When patients have problems with eating
or digestion, it is sometimes necessary to provide nutrition with artificial food, which is
specially formulated to provide the right balance of fats, proteins, sugars, vitamins and
minerals. These artificial preparations can be delivered into the gut to be absorbed in
the usual way, which is known as Enteral Nutrition. If the gut is working normally to
absorb food and nutrients, then Enteral Nutrition is the preferred way of delivering
nutritional support. In some patients, enteral nutrition may have to be delivered into the
gut through a tube, but in others it may be possible for them to take this by mouth
(BAPEN, 2018).
II. Definition
Enteral Nutrition (EN) refers to the delivery of nutrients into the gastrointestinal
tract either by mouth or through a feeding tube. It includes food, oral supplements,and
formulas created specifically to prevent malnutrition and accommodate nutrient needs
in various disease states. Obstacles to oral intake have many causes, including
gastrointestinal disease, swallowing inabilities, or increased nutrient needs related to
critical illness or wound healing.
In a closed enteral system the container or bag is prefiled with sterile liquid
formula by the manufacturer, and is ready to administer. In an open enteral system, the
person administering the feeding must open and pour the feeding in the container or
bag. Both systems are effective sanitation is a priority.
III. Indication/Contradiction
Indications: (Mahan, et al., 2017)
1. Conditions that make the patient unable to eat
a. Neurologic disorders (dysphagia)
b. Facial trauma
c. Oral or esophageal trauma
d. Congenital anomalies
e. Respiratory failure (on a ventilator)
f. Traumatic brain injury
g. Comatose state
h. GI surgery (e.g., esophagectomy)
2. Condition that prevent the patient from eating enough
a. Hypermetabolic states such as with burns
b. Cancer
c. Heart failure
d. Congenital heart disease
e. Impaired intake after orofacial surgery or injury
f. Anorexia nervosa
g. Failure to thrive
h. Cystic fibrosis
3. Conditions that result in impaired digestion, absorption, and metabolism in the
patient
a. Severe gastroparesis
b. Inborn errors of metabolism
c. Crohn’s disease
d. Short bowel syndrome with minimum resection
e. Pancreatitis
Contraindications:
1. According to Howard (2009) general contraindications include:
a. absence of intestinal function due to failure, severe inflammation or, in
some instances, post operative stasis
b. complete intestinal obstruction
c. inability to access the gut e.g. severe burns, multiple trauma
d. high loss intestinal fistula
e. relative contraindication to tube feeding is also increased likelihood of
opportunistic infection e.g. maxillo-facial surgery or oncology treatments
f. ethical considerations e.g. terminal care.
2. Additionally, an update from Singer, et al. (2019) expounds that
contraindications also include:
a. Critically ill patients with:
i. Uncontrolled shock,
ii. Uncontrolled hypoxemia and acidosis
iii. Uncontrolled upper GI bleeding
iv. Gastric aspirate >500 ml/6 h
v. Bowel ischemia
vi. Bowel obstruction
vii. Abdominal compartment syndrome,
viii. High-output fistula without distal feeding access.
IV. Algorithm
V. Different Access/ Routes
Determination of the site and route of EN should consider an individual’s
anticipated length of feeding time; their medical condition or disease state, including
anatomical barriers within the gastrointestinal tract; and the surgical options for that
individual.
1. Percutaneous endoscopic
gastrostomy (PEG-J) - is the
most common long-term
tube placement method.
After a small incision is
made, a needle is placed
through the abdominal
wall and into the stomach
so that a guidewire can be
placed through the
needle.
2. Percutaneous endoscopic
jejunostomy (PEJ)- if the
patient has gastric
complications, a
percutaneous endoscopic jejunostomy can be performed. If there is an existing
gastrostomy tube, a transpyloric feeding tube can be placed through the
previously placed PEG tube and placed endoscopically into the jejunum.
1. Bolus Feeding
a. Bolus feeding is a way of receiving a set amount of feed as required,
without use of a feeding pump. EN is administered via a syringe or gravity
drip over a 4-10-min period. Delivered four to eight times per day; each
feeding lasting about 15 to 30 minutes. Feedings are given at 50-100 ml
every 4 hours.
b. Used for Nasogastric and Gastrostomy tubes.
c. Gravity Feeding
i. Gravity feeding (with or without a gravity feeding set), where
gravity naturally draws the feed through into feeding tube,
d. Syringe Feeding
i. Syringe feeding, where the feed may need help to be pushed
through your feeding tube using the syringe with its plunger.
2. Intermittent Drip
a. In intermittent feeding, EN is administered over 20-60 min every 4-6 h with
or without a feeding pump.
b. Formula administration is initiated at 100 to 150 mL per feeding and
increased incrementally as tolerated. Success with this method of feeding
depends largely on the degree of mobility, alertness, and motivation of
the patient to tolerate the regimen.
3. Continuous Drip
a. This method provides a slow infusion of feedings into the stomach or small
intestine on an hourly basis. Using this method decreases risk for aspiration
and gastric distention. It tends to be the most easily tolerated because of
its gradual delivery of feeding, and it allows for greater nutrient uptake in
patients who may have marginal absorptive capacity. It also reduces the
effect of thermogenesis.
b. The feeding rate goal, in milliliters per hour, is set by dividing the total daily
volume by the number of hours per day of administration (usually 18 to 24
hours). Feeding is started at one quarter to one half of the goal rate and is
advanced every 8 to 12 hours to the final volume.
c. Used for Nasojejunal, Nasodoudenal, Jejunostomy tubes
Magnesium: 280 mg
Potassium: 2667 mg
Phosphorus: 833 mg
Calcium: 867 mg
Preparation: Ready to hang (RTH)
Caloric Density: 1.0 kcal/ml
Flavor: Unflavored
Elemental formulas contain individual amino acids, are low in fat, especially
Long chained triglycerides (LCTs), varying length, simple carbohydrates, and
Medium chain triglycerides MCTs and as such, are thought to require minimal
digestive function and cause less stimulation of exocrine pancreatic secretion. In
many products, MCT is the predominant fat source, and can be absorbed
directly across the small intestinal mucosa into the portal vein in the absence of
lipase or bile salts; they are believed to be beneficial in malabsorptive states.
They are also considered to be advantageous in patients with acute
pancreatitis, and in those with other malabsorptive states.
Specialty formulations are available for patients with unique ‘‘disease specific’’ or
‘‘organ specific’’ nutritional requirements. This is a growing area of enteral nutrition,
where improved knowledge of disease processes has led to the development of a
multitude of specialty products. Currently specially designed formulas exist for liver
disease, renal disease, diabetes, pulmonary insufficiency, heart failure, GI dysfunction
as well as situations of metabolic stress such as trauma or sepsis. These products are
more expensive than standard enteral nutrition and may result in complications when
used inappropriately.
For patients with acute or chronic renal disease or those needing electrolyte
restriction, For oral or tube feeding.
Formulated to meet requirements for those with renal insufficiency, and help
delay CKD progression for patients on pre dialysis stage
Oxepa is a 1.5 kcal/ml tube feed enriched with eicosapentaenoic acid (EPA),
gamma linolenic acid (GLA) and antioxidants. It has been specifically
designed for the management of people with Acute Lung Injury (ALI), Acute
Respiratory Distress Syndrome (ARDS), and/or Systemic Inflammatory Response
Syndrome (SIRS). It is available in a 500 ml Ready to Hang bottle, which
attaches directly to Abbott giving sets.
Polymeric
Compleat® Pediatric Caloric density 0.6 kcal/mL Short or long term tube
Reduced Calorie, Nestlé Protein 20 % feeding regimen for those
Health Science Carbohydrates 51% who prefer a formula with
Fat 29% food ingredients
May help address feeding
intolerance common in
children with
developmental disabilities
Reduced caloric needs
Support of normal growth
Bowel management
Peptamen Junior® HP, Caloric density 1.2 kcal/mL Impaired GI function (short
Nestlé Health Science Protein 16% bowel syndrome, cancer
Carbohydrate 50% cachexia, cerebral palsy,
Fat 34% Cystic fibrosis, Crhon’s
Sodium 6 mEq Disease, Malabsorption,
Calcium 18 mEq Chronic Diarrhea, delayed
Potassium 12 mEq gastric emptying, growth
Chloride 8 mEq failure, Malnutrition
Protein energy malnutrition
Critical Illness /trauma
Early enteral feeding
Transition from TPN
Peptamen Junior® Fiber, Caloric density 1.0 kcal/mL Impaired GI function (Short
Nestlé Health Science Protein 12% bowel syndrome, Cerebral
Carbohydrate 55% palsy, Cystic fibrosis,
Fat 33% Crohn’s disease,
Sodium 5 mEq Malabsorption, Chronic
Calcium 15 mEq diarrhea, Delayed gastric
Potassium 10 mEq emptying, Growth failure,
Chloride 7 mEq Malnutrition)
Bowel management
PediaSure® Peptide 1.5 Caloric density 1.5 cal/mL children 1-13 years with
Cal, Abbott Protein 12% malabsorption,
Carbohydrate 53% maldigestion, and other GI
Fat 35% conditions. It is designed to
meet the nutritional and
caloric needs of kids who
require higher caloric
density, have fluid
restrictions, and are at risk
for malnutrition. l For oral or
tube feeding. l For
supplemental or sole-
source nutrition. l Use under
medical supervision
Allergy or intolerance to
milk, soy, corn, or artificial
sweeteners, flavors, colors,
or preservatives
Malabsorption
Elemental/Semi-Elemental
A.
Modular Formula
B. Renal
C. Diabetes
D. Cancer (Catigbe)
Nutrition/
Janice L., & Carol S. Chapter 14: Food and Nutrition Delivery: Nutrition Support
Methods. Kathleen L., Sylvia E. & Janice L. (2011) Krause’s Food and the
Nutrition Care Process 13th Edition Elsevier Inc.: Saunders. Pg no. 312-313
Rombeau JL, Rolandelli RH, editors: Clinical nutrition: enteral tube feeding,
Philadelphia, 1997, Saunders; Merck Manual online. Accessed 29 May 2010
from http://www.merckmanuals.com/professional/
sec01/ch003/ch003b.html.
Taylor BE, McClave SA, Martindale RG, et al. Guidelines for the Provision and
Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:
Society of Critical Care Medicine (SCCM) and American Society for
Parenteral and Enteral Nutrition (A.S.P.E.N.). Crit Care Med. Feb
2016;44(2):390-438.
Todd SR, Kozar RA, Moore FA. Nutrition support in adult trauma patients. Nutr
Clin Pract. 2006 Oct;21(5):421-9. doi: 10.1177/0115426506021005421. PMID:
16998141.
White JV, Guenter P, Jensen G, et al. Consensus Statement: Academy of
Nutrition and Dietetics and American Society for Parenteral and Enteral
Nutrition: Characteristics Recommended for the Identification and
Documentation of Adult Malnutrition (Undernutrition). JPEN J Parenter Enteral
Nutr. 2012; 36:275-283
Wischmeyer P. Enteral Nutrition Can Be Given to Patients on Vasopressors.
SCCM. 2020; 48:123
https://www.espen.org/files/ESPEN-Guidelines/ESPEN-practical-guideline-
clinical-nutrition-in-cancer.pdf
https://www.todaysdietitian.com/newarchives/tdjune2008pg46.shtml
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517016/
https://www.isdi.org/wp-content/uploads/2018/11/ISDI-Position-Statement-A-
new-era-for-diabetes-specific-enteral-nutrition-policy-2018-06-25.pdf
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P.,
Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., Preiser, J. C., van Zanten, A.,
Oczkowski, S., Szczeklik, W., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition
in the intensive care unit. Clinical nutrition (Edinburgh, Scotland), 38(1), 48–79.
https://doi.org/10.1016/j.clnu.2018.08.037
Howard, P. (2009), Basics in clinical nutrition: Enteral nutrition. European e-Journal of
Clinical Nutrition and Metabolism, 4 (5), e223-225. Retrieved from
https://clinicalnutritionespen.com/article/S1751-4991(09)00040-7/fulltext#relatedArticles
Mahan, L.., Escott-Stump, S., Raymond, J., Krause, M. V. (Eds.) (2017) Krause's food & the
nutrition care process. St. Louis, Mo. : Elsevier/Saunders.
Sources:
https://data.schwabenorthamerica.com/elementaldiets/list
Acquired: 03//22/2022
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/polymeric-
enteral-nutrition-formula
Acquired: 03//22/2022
https://med.virginia.edu/ginutrition/wp-content/uploads/sites/199/2015/11/
MakolaArticle-Dec-05.pdf
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #34
PRACTICAL GASTROENTEROLOGY • DECEMBER 2005
Acquired: 03//22/2022
http://www.csun.edu/~cjh78264/tubefeeding/formulas/p04.html
Acquired: 03//22/2022
http://www.elsevier.com/locate/clnu
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 4 (2009) e212–e215
Basics in clinical nutrition: Commercially prepared formulas
—---
https://nutrition.abbott/in/product/glucerna-sr
https://kalbeinternational.com/prescription/nephrisol-english/
https://nutrition.abbott/in/product/nepro-lp
https://nutrition.abbott/in/product/nepro-hp